Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

GENTAMICIN SULFATE

GENTAMICIN SULFATE

Standard Dose
EQ 40MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview GENTAMICIN SULFATE is listed in Drugs@FDA under application 215237 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient GENTAMICIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 40MG BASE/ML Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-01-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview GENTAMICIN SULFATE is listed in Drugs@FDA under application 215237 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GENTAMICIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 40MG BASE/ML Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-01-08 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.